GBC BioHUB, one innovation high-tech enterprise in China with ISO9001, participates and share-holds four production bases of microbial fermentation and complex synthesis. GBC’s headquarter office is located in Beijing, China, and we also have regional business offices in India, Korea, Germany, Italy, USA, Finland, Russia, etc.

As one leading solution provider in the bio-industry, GBC relies on and integrates well-known universities, institutes and R&D companies at home and abroad. GBC’s R&D team is led by academicians and experts and networks with global R&D partners in major developed economies. Based on the R&D platform of synthetic biology and the sub-platforms of rational molecular design, gene editing and biosynthesis engineering, GBC develops new process routes to achieve the production of target molecules by the biosynthesis in engineered bacteria, fungi or plants, and improves existing microbial strains, enzymes or plants to enhance the production efficiency of target molecules for reducing production costs and improving product quality. GBC provides biotechnology innovation, enzyme or strain improvement, process optimization, process scale-up, customized product or metabolites, engineering consulting, technology transfer, project crowd funding, contract research (CRDO) and contract manufacturing (CDMO) services via public co-sharing platform.